Last updated: March 6, 2024
Sponsor: Institute for Clinical and Experimental Medicine
Overall Status: Active - Recruiting
Phase
N/A
Condition
Gastroesophageal Reflux Disease (Gerd)
Esophageal Disorders
Heartburn (Pediatric)
Treatment
Physiotherapy
Control group
Clinical Study ID
NCT05326113
IClinicalEM4
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- esophageal achalasia (or other primary motility disease) treated by per oralendoscopic myotomy (POEM)
- symptomatic post-POEM reflux and/or esophagitis LA A/B/C (grade by The Los AngelesClassification) present 3 months after POEM surgery
- positive finding on esophageal 24hours pH Test 3 months after POEM surgery
- signed informed consent
Exclusion
Exclusion Criteria:
- reflux symptoms previously to the POEM surgery (except regurgitation)
- repeated POEM surgery
- Esophagitis of LA grade D
- asymptomatic pathologic reflux without signs of esophagitis 3 months post POEM surgery (patient is not indicated to use proton pump inhibitor "PPI" drugs)
- previous gastric surgery
- patients undergoing cancer treatment
- pregnancy
- known allergy or intolerance of proton pump inhibitor drugs
- other circumstances preventing participation in the study
- Inability to obtain informed consent
Study Design
Total Participants: 30
Treatment Group(s): 2
Primary Treatment: Physiotherapy
Phase:
Study Start date:
October 31, 2021
Estimated Completion Date:
January 18, 2025
Study Description
Connect with a study center
Institute for Clinical and Experimental Medicine
Prague 4, Prague 14021
CzechiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.